Board-certified Family Medicine · Diplomate, ABOM · Reviewed Jun 20, 2026
You did the math at the kitchen table. The headline price looked fine. Then the real bill showed up, and it had numbers on it nobody mentioned. A lab fee here. A visit fee there. A dose change that quietly cost more. By month three you were paying almost double what the ad promised, and you still could not say where the extra money went. That gap between the price you are shown and the price you actually pay is the whole story of GLP-1 costs in 2026. Every line of it, laid out plainly, so the next bill holds no surprises.
The short answer
A GLP-1 program has up to five cost lines: the medication, dose-change (titration) costs, baseline and follow-up labs, the visit or membership fee, and what insurance does or does not cover. In 2026, cash-pay totals run roughly $150 to $700 a month depending on the drug and path. Individual costs vary by plan and provider. This is educational content, not medical or financial advice; a licensed clinician decides treatment.
What you will learn
The five separate numbers that make up your true monthly cost
How a dose change (titration) can move your price mid-treatment
What labs cost up front and along the way, and who orders them
What insurance actually covers in 2026, and how often it does not
How cash, insurance, and compounded paths really compare
The four numbers any provider should show you before charging your card
Chapter 01 · The full picture
The five numbers hiding in one monthly price
Most people think a GLP-1 costs one number. It does not. It costs up to five, and they do not all show up on day one.
Here they are, plainly: the medication itself, the cost of changing your dose over time (titration), your labs, the visit or membership fee, and the slice insurance leaves you to pay. Some providers fold a few of these together. Some break them apart. The trouble starts when a brand shows you one number and lets the other four arrive later, one quiet charge at a time.
So before any price impresses you, ask which of the five it includes. That single question changes the whole conversation.
Ask which of the five cost lines a price includes. That single question changes the whole conversation.
Why does the advertised price feel so different from the real bill? Because the advertised price is usually just line one: the medication. It rarely includes labs, almost never includes the cost of moving to a higher dose, and may or may not include the visit fee. A $199 headline can become a $340 month once the other lines land. None of that is hidden if you know to look. The problem is that most brands do not show you where to look.
Chapter 02 · Cost line one
The medication, and why it has so many price tags
The medication is the number everyone quotes, and it is also the most volatile. The same drug can cost $149 or $699 a month in 2026 depending on the version, the dose, and where you buy it.
Branded injectables (cash pay, 2026 illustrative ranges). Through manufacturer direct programs, Wegovy® injectables ran about $199 a month for early fills, then up to $349 a month. Zepbound® vials dropped to roughly $299 to $449 depending on dose. The Zepbound® KwikPen ran up to $699 a month at the highest doses. All prices are illustrative snapshots that change; always confirm current pricing directly with the provider.1, 3
Branded oral pills (cash pay, 2026 illustrative ranges). The oral Wegovy® pill started around $149 a month for the 1.5 mg starter dose through NovoCare, rising to about $299 a month at higher therapeutic doses. Foundayo™ (the orforglipron pill) topped out around $349 a month at launch.2
Compounded GLP-1s through telehealth (cash pay, 2026 illustrative ranges). Patient-specific compounded semaglutide commonly started around $169 a month, with starter bundles near $299 for the first 12 weeks and higher doses in the $399 to $499 range. Compounded tirzepatide typically started near $299 a month.
Important: compounded framing
A compounded drug is prepared for a specific patient under a 503A prescription. It is not the same product as a branded, FDA-approved drug, and no honest provider will describe it as a copy or equivalent of one. It is a distinct preparation, not FDA-approved, and not equivalent to the brand.
illustrative high end, branded injectable top dose, cash pay 2026
Price ranges are 2026 snapshots from third-party sources and will change. Confirm your own cost before you pay.
Which medication is cheapest for me? There is no single answer, and anyone who gives you one is guessing. Cheapest depends on your starting dose, how high you titrate, whether you want a pill or an injection, and whether you have any coverage. The point is not to chase the lowest sticker. It is to see the full path, because the cheapest month-one price is sometimes the most expensive month-six price.
Titration: the cost that moves while you are not looking
Titration is the slow climb from a low starting dose to your maintenance dose. It is normal, it is clinical, and on many price lists it quietly raises your cost over the first several months.
Most GLP-1 treatment starts low and steps up. That ramp protects you from side effects. But with several pricing models, each step up means a higher monthly charge, because more medication costs more to make or buy. So the $169 you paid in month one is not necessarily the $169 you pay in month four. Nobody is cheating you. The price simply followed the dose. The catch is whether your provider told you that on day one or let you find out at the pharmacy.
A composite illustration. A reader signed up at an advertised $199. She felt good about it. By her fourth fill she was at a higher dose and paying $340, and she could not remember anyone explaining the climb. The medicine was working fine. The billing had simply outrun her expectations. That gap, between what she understood and what she was charged, is the exact thing a transparent provider is supposed to close before it opens.
Ask for the dose ladder and the price at each rung before you start. That is not extra homework. That is the full price.
How do I know what titration will cost before I start? Ask for the dose ladder and the price at each rung. A provider who prices by dose should be able to hand you the whole staircase: starting dose and price, each step up and price, and maintenance dose and price. If they can show you only the first step, you are not seeing your real cost. You are seeing a teaser.
Chapter 04 · Cost line three
Labs: the line item most ads skip entirely
Labs are the cost almost no advertisement mentions, and they are real. Baseline blood work before you start, plus periodic follow-up labs, are a normal part of safe GLP-1 care.
Before a clinician prescribes, they often want a baseline: things like A1C, a metabolic panel, and a lipid panel, to see your starting health and rule out reasons not to prescribe. Cash-pay prices at national labs in 2026 ran roughly $40 to $80 for a comprehensive metabolic panel, $38 to $75 for A1C, and $45 to $85 for a lipid panel. A bundled baseline weight-management panel often landed around $239 out of pocket. All figures are illustrative ranges from third-party sources and vary by provider and location.
Now the question that actually matters for your wallet: are those labs included in your program price, billed to your insurance, or charged to you separately? All three models exist. A provider that includes baseline labs in the program looks more expensive on the sticker and may be cheaper in reality. One that advertises a low price and bills labs separately can flip the math. Same care, very different bill.
Labs are not optional extras. They are part of safe care. The only question is who shows you the price before the blood draw.
Will I pay for labs more than once? Probably, yes, and that is normal. Beyond the baseline, your clinician may order follow-up labs periodically to keep treatment safe. Budget for them as a recurring small line, not a one-time fee. A good program tells you the expected lab cadence up front so you are never surprised by a second or third draw.
Chapter 05 · Cost line four
The visit or membership fee
The visit fee, sometimes packaged as a monthly membership, covers the clinical care around your medication: the consultation, the prescription, and the follow-up. It is a separate number from the drug, and how it is structured changes your total a lot.
Some brands bundle the visit and follow-up into one monthly membership. Some charge per visit. Some advertise a free consultation and recover the cost elsewhere. None of these is automatically wrong. What matters is that the fee is named and shown, not buried. A clean model tells you: here is the membership, here is what it includes (physician access, follow-ups, messaging), and here is whether the medication is on top of it or inside it.
Watch the word included. It does heavy lifting. Included follow-ups can be the difference between a calm second month and a surprise charge when you have a question about a side effect.
Is a membership fee worth it, or just another charge? It depends entirely on what the membership buys. If it covers unlimited physician messaging, dose adjustments, and follow-up visits, it can be the best value in the whole bill, because the support after your prescription is where most programs fall short. If it is a fee that buys you nothing you can name, that is a flag. The test is simple: ask what the membership includes, in plain words, and see if the answer is specific.
Chapter 06 · Cost line five
What insurance actually covers (and how often it does not)
Insurance is the most hoped-for number and the least reliable. In 2026, coverage for GLP-1 weight loss medication is real for some people and absent for many, and it is moving in the wrong direction for affordability.
Here is the honest picture. Major insurers including Aetna, Cigna, BCBS, and UnitedHealthcare may cover Wegovy® and Zepbound® on some group plans, but almost always with prior authorization, and often with extra hurdles. Many plans exclude these medications from the formulary completely. Aetna commonly requires a BMI of 30 or more (or 27 with a related condition) plus documented lifestyle effort. Cigna may require step therapy, meaning you try a cheaper medication first. And coverage frequently depends on whether your employer chose to include obesity medication at all.
The harder truth: coverage is slipping. From 2025 to 2026, about 12 million people lost Zepbound® coverage and 12 million lost Wegovy® coverage, and the number of commercially insured people with no Wegovy® coverage rose to roughly 41 million, a 42% jump in a year.4
There is one bright spot worth knowing. The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027, offering a flat $50 copay that does not climb as your dose climbs. If you are on Medicare, that single program can reshape your math.5
How do I find out if I am actually covered? Call the number on your insurance card and ask three specific questions. One: is the GLP-1 medication on the formulary for weight loss, not just diabetes? Two: what does prior authorization require, and is there step therapy? Three: what is my copay at each dose? Write the answers down with a date. Coverage decisions change, and a dated note protects you when a denial shows up later.
Cash-pay branded
Insurance-covered branded
Cash-pay compounded (503A)
Typical 2026 monthly cost
~$199 to $699 by drug and dose
$0 to $50 copay if approved; full price if denied
~$169 to $499 by drug and dose
Predictability
High; you see the sticker
Low; depends on prior auth, step therapy, employer choice
High; you see the sticker
Hurdles
None beyond eligibility
Prior authorization, possible step therapy, possible denial
Requires patient-specific prescription
Labs
Often separate; ask
Often billed to insurance; ask
Often separate; ask
Best when
You want certainty and no insurance maze
Your employer plan clearly covers obesity meds
You want a patient-specific option and clear cash pricing
Watch for
Titration raising the monthly price
Coverage being dropped mid-year
A provider implying it equals a branded drug (it does not)
All figures are 2026 illustrative ranges and vary by plan, provider, dose, and location. Always confirm your own numbers before you pay. Individual costs vary. Swipe to see the full table on a phone.
Chapter 07 · The standard
The four numbers a provider owes you before charging your card
A good GLP-1 provider shows you the full monthly medication cost, the titration cost at each dose, the lab cost and cadence, and the cancellation policy, all before your card is charged. If a brand cannot give you all four, walk away. That is not a high bar. It is the floor.
This is what billing trust looks like in practice. Not a promise on a homepage. Four specific numbers, shown before money moves, plus a cancellation policy you can read in one sitting and act on without a phone call. The FTC full-cost-disclosure expectation exists for exactly this reason: you are owed the complete price before you commit, not after.6
The four numbers to ask for
The medication price at your starting dose
The titration cost at each dose step
The lab cost and how often labs are ordered
The cancellation policy, in writing, before you pay
This is the standard a good provider should meet. sipra is built around it. You can read how the pricing page lays out every line before anything is charged, and there is no charge until your physician approves.
What does a fair cancellation policy look like? It looks like this: cancel at any time, online, without a phone call, with no charge for a fill you have not received. If canceling requires a call to a retention line, or if you are billed for the next cycle the moment you hesitate, that is a billing model designed to keep you, not serve you. Read the cancellation terms before you start. It is the clearest signal of how a brand will treat you on your worst day, not your first.
Chapter 08 · Action steps
Before you pay, do these three things
You now know the five numbers and the four a provider owes you. Here is how to use that, today.
Get all five numbers in writing. Medication at your dose, titration at each step, labs and how often, the visit or membership fee, and your insurance share. If a provider will not put all five on paper, that is your answer.
Call your insurer and ask the three questions. Is it on the formulary for weight loss, what does prior authorization require, and what is my copay at each dose? Write down the answers with the date.
Read the cancellation policy first. Confirm you can cancel at any time, online, with no charge for an unshipped fill. How a brand handles leaving tells you how it will handle everything else.
Do those three, and the bill that arrives will hold no surprises. That is the entire goal.
Ask for the full cost before you commit
The price you see on day one is not always the price you pay by month three. Five lines, four questions, and one honest cancellation policy tell you everything you need to know before your card is ever charged.
Get all five in writing. Medication, titration, labs, membership fee, and your insurance share, all named before you pay.
Call your insurer today. Ask: is it on the formulary for weight loss, what does prior auth require, and what is my copay at each dose?
Read the cancellation terms. Cancel at any time, no charge until your physician approves, no phone call required. If a brand cannot say that clearly, keep looking.
*Price includes medication only. Active $99/mo Sipra membership required.
Frequently asked questions
Every medication on sipra is prescribed by a licensed physician, so your care always starts with a visit. Your sipra membership gives you ongoing access to those physician visits, so you can check in, adjust your plan, and ask questions whenever you need, without paying per visit. It is how we keep high-quality care convenient: one membership, physician access whenever you need it, and support at every step.
The most common reason is titration. As your dose steps up to its maintenance level, many pricing models raise the monthly charge, because a higher dose costs more. Ask your provider for the price at every dose so you can see the full path before it happens. Some providers hold one price across doses; ask which model yours uses.
Usually not. Baseline and follow-up labs are frequently a separate cost, billed to you or to your insurance. In 2026, cash-pay baseline panels run roughly $40 to $239 depending on what is ordered. Ask whether labs are inside your program price or on top of it before you commit.
Sometimes. Some insurers may cover Wegovy and Zepbound, but almost always with prior authorization, often with step therapy, and often only if your employer opted into obesity-medication coverage. Many plans exclude these medications entirely. Coverage has also been narrowing in 2026, so confirm your own plan in writing with a date.
No, and that framing is wrong. A 503A compounded medication is prepared for a specific patient under a prescription. It is not a copy, generic, or equivalent of a branded FDA-approved drug, and no honest provider will describe it that way. It is a distinct option with its own pricing, which should be shown to you in full.
There is no universal cheapest path, because it depends on your dose, your drug, and your coverage. The honest move is to compare the all-in cost across all five lines (medication, titration, labs, visit fee, insurance share) for each path, rather than chasing the lowest headline. The lowest month-one sticker is sometimes the highest month-six bill.
Budget for medication plus a baseline lab panel plus any visit or membership fee, and assume the medication line may rise as you titrate. A realistic first-quarter range in 2026 spans widely, from a low double-digit copay if you are well covered to several hundred dollars a month cash. The point is to get all five numbers in front of you before month one, not after month three.
Sources
AJMC. "Trump Announces Deals With Eli Lilly, Novo Nordisk for Lower Weight Loss Drug Prices." Updated 2026. ajmc.com
NovoCare. "Wegovy (semaglutide) pricing and savings." Accessed June 2026. novocare.com
Eli Lilly and Company. "Zepbound (tirzepatide) and LillyDirect self-pay pricing." Accessed June 2026. lilly.com
KFF (Kaiser Family Foundation). "KFF Health Tracking Poll: GLP-1 drug coverage and affordability." 2026. kff.org
CMS (Centers for Medicare & Medicaid Services). "Medicare GLP-1 Bridge and weight-management coverage." Accessed June 2026. cms.gov
U.S. Federal Trade Commission. "Negative Option Rule." Accessed June 2026. ftc.gov
Trademark attribution. Wegovy® is a registered trademark of Novo Nordisk A/S. Zepbound® and Foundayo™ are trademarks of Eli Lilly and Company. sipra is not affiliated with or endorsed by these companies.
We use cookies and similar technologies for analytics and advertising. Third-party data sharing excludes health and genetic information. By using our site, you agree to our Privacy Policy.